Patents by Inventor Subrata Batabyal

Subrata Batabyal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240157169
    Abstract: The present invention generally relates to an image guided variable spot stimulation-based electrophysiology assessment device for different biomedical applications. Specifically, the invention relates to application of the device to perform image-guided functional assessment upon variable spot optical stimulation of light-activatable biological specimens to determine changes in the functional health during disease progression and therapy. More specifically, the invention relates to the application of the device in the diagnosis of visual and neurological disorders.
    Type: Application
    Filed: November 16, 2023
    Publication date: May 16, 2024
    Inventors: Samarendra Kumar Mohanty, Sanghoon Kim, Michael Carlson, Subrata Batabyal
  • Patent number: 11890230
    Abstract: The present invention generally relates to an image-guided laser irradiation device for targeted ablation, stimulation, molecular delivery and therapy. Specifically, the invention relates to application of the device in therapies needing precise and targeted removal of a sample, or delivery of impermeable molecules for therapeutic outcome. More specifically, the invention relates to the application of the device in the therapy of visual disorders.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: February 6, 2024
    Assignee: Nanoscope Technologies, LLC
    Inventors: Samarendra Mohanty, Sanghoon Kim, Subrata Batabyal, Michael Carlson
  • Publication number: 20230382955
    Abstract: The present invention generally relates to the novel method, compositions and applications of mechanosensitive channels in therapeutics for visual, neurological and other disorders. Specifically, the invention relates to exploitation of mechanosensitive channels' intrinsic property as a transgenic pressure modulator and alternative outflow actuator in the treatment of different diseases such as glaucoma, blood pressure and other diseases involving of cells prone to mechanical or osmotic stress. Furthermore, the invention relates to exploitation of mechanosensitive channels for stimulation of cells enabling therapies for different diseases including pain, as well as molecular delivery to cells triggered by internal and/or external mechanical stimuli.
    Type: Application
    Filed: January 9, 2023
    Publication date: November 30, 2023
    Inventors: Samarendra Kumar Mohanty, Subrata Batabyal, Darryl Narcisse, Adnan Dibas, Chinenye Abiodun Idigo
  • Publication number: 20220162275
    Abstract: This invention, in one aspect, relates generally to compositions and methods for modulating cellular activities by synthetic opsins. Further, the invention provides method for the use of synthetic opsins for vision restoration and other applications, wherein the amino acid sequence of the synthetic opsin is modified to provide enhanced light sensitivity, kinetics and ion-selectivity.
    Type: Application
    Filed: November 22, 2021
    Publication date: May 26, 2022
    Applicant: Nanoscope Therapeutics, Inc.
    Inventors: Samarendra Mohanty, Subrata Batabyal
  • Patent number: 11154194
    Abstract: Principles of the present disclosure are directed to novel methods and devices for focal or global optical stimulation of retina and detecting activity of the retina by collecting and processing the back-scattered optical signal from the retina (Optical RetinoGram). Specifically, the invention provides device and method for quantitatively determining the layer specific activity of retina from the acquired intrinsic back reflected signal by monitoring phase/intensity fluctuations and thereafter employing multifractality algorithm on optical signal for obtaining various multifractal parameters such as width of singularity spectrum, Hurst exponent, fractal dimension, locally connected fractal mapping as well as artificial intelligence based classification for the use of diagnosis of retinal degenerative/ocular disease(s) and asses the progression of diseases or recovery of function due to one or more treatment by therapeutic drugs, devices, protocols.
    Type: Grant
    Filed: November 4, 2018
    Date of Patent: October 26, 2021
    Inventors: Samarendra Kumar Mohanty, Subrata Batabyal
  • Publication number: 20210177649
    Abstract: The present invention generally relates to an image-guided laser irradiation device for targeted ablation, stimulation, molecular delivery and therapy. Specifically, the invention relates to application of the device in therapies needing precise and targeted removal of a sample, or delivery of impermeable molecules for therapeutic outcome. More specifically, the invention relates to the application of the device in the therapy of visual disorders.
    Type: Application
    Filed: December 7, 2020
    Publication date: June 17, 2021
    Inventors: Samarendra Mohanty, Sanghoon Kim, Subrata Batabyal, Michael Carlson
  • Publication number: 20190282088
    Abstract: Principles of the present disclosure are directed to novel methods and devices for focal or global optical stimulation of retina and detecting activity of the retina by collecting and processing the back-scattered optical signal from the retina (Optical RetinoGram). Specifically, the invention provides device and method for quantitatively determining the layer specific activity of retina from the acquired intrinsic back reflected signal by monitoring phase/intensity fluctuations and thereafter employing multifractality algorithm on optical signal for obtaining various multifractal parameters such as width of singularity spectrum, Hurst exponent, fractal dimension, locally connected fractal mapping as well as artificial intelligence based classification for the use of diagnosis of retinal degenerative/ocular disease(s) and asses the progression of diseases or recovery of function due to one or more treatment by therapeutic drugs, devices, protocols.
    Type: Application
    Filed: November 4, 2018
    Publication date: September 19, 2019
    Applicant: Nanoscope Technologies, LLC
    Inventors: Samarendra Kumar Mohanty, Subrata Batabyal